Heather J. Chalfin, Grzegorz T. Gurda, Hans-Joerg Hammers, George J. Netto, Trinity J. Bivalacqua

Canadian Journal of Urology, Vol.20, No.5, pp. 6964-6967, 2013

Abstract Small renal cell carcinoma (RCC) tumors are believed to have a negligible risk of metastasis. We report on a 77-year-old man presenting with extremity weakness who was found to have a 2.5 cm brain metastasis from a subsequently discovered 1.6 cm clear cell RCC primary tumor. We review what is known about synchronous and metachronous metastasis from small renal tumors and prognostic features informing treatment for such lesions. More >

Fahad Alyami, Jeffrey Himmelman, Thomas Whelan

Canadian Journal of Urology, Vol.20, No.5, pp. 6962-6963, 2013

Abstract A search of the literature finds that there have been many case reports documenting a wide array of objects found within the bladder, ranging from magnets and paper clips to telephone and aluminum wire. The goal of treatment is to remove the object quickly, using the least invasive method possible. Therefore, the ideal treatment is removal through endoscopic means; however, in some cases, the size, mobility and shape of the foreign body can prevent its removal endoscopically and more invasive means must be employed. We present a case of a patient who inserted 150 magnetic More >

Roger F. Valdivieso, Pierre-Alain Hueber, Kevin C. Zorn

Canadian Journal of Urology, Vol.20, No.5, pp. 6957-6961, 2013

Abstract Radical prostatectomy remains the standard treatment for long term cure of clinically localized prostate cancer, offering excellent oncologic outcomes, with cancer-specific survival approaching 95% at 15 years after surgery. The introduction of the “da Vinci Robotic Surgical System” (Intuitive Surgical, Sunnyvale, CA, USA) has been another important step toward a minimally invasive approach to radical prostatectomy. Technologic peculiarities, such as three-dimensional vision, wristed instrumentation with seven degrees of freedom of motion, lack of tremor, a 10x-magnifcation and a comfortable seated position for the surgeon has added value to the surgeon and patient. In this frst More >

Lane S. Palmer

Canadian Journal of Urology, Vol.20, No.5, pp. 6956-6956, 2013

Abstract This article has no abstract. More >

Ahmed S. Safwat¹, Hisham M. Hammouda¹, Adel A. Kurkar¹, Nabil K. Bissada²

Canadian Journal of Urology, Vol.20, No.5, pp. 6951-6955, 2013

Abstract Introduction: To evaluate the outcome of bilateral laparoscopic Fowler-Stephens orchidopexy (BLFSO) for bilateral intra-abdominal testes.
Materials and methods: Prospectively, all patients with bilateral intra-abdominal testes between 2006 and 2010 were included in this study. Patients’ data were analyzed for age, procedure whether single stage or staged Fowler-Stephens, intraoperative and postoperative complications, and follow-up results.
Results: BLFSO was performed in a total of 48 testes in 24 boys with a median age of 31.6 months (range 12 to 150). All procedures were performed on an outpatient basis. Of the 24 boys, six were managed with a single stage BLFSO. More >

Lee E. Ponsky

Canadian Journal of Urology, Vol.20, No.5, pp. 6950-6950, 2013

Abstract This article has no abstract. More >

Vimoj J. Nair¹, Janos Szanto², Eric Vandervoort², Ilias Cagiannos³, Rodney Breau³, Colin Malone¹, Leonard Avruch⁴, Jason Pantarotto¹, Shawn Malone¹

Canadian Journal of Urology, Vol.20, No.5, pp. 6944-6949, 2013

Abstract Introduction: Stereotactic ablative body radiotherapy (SABR) is currently under study regarding its clinical application in management of patients with kidney tumors. CyberKnife can accurately deliver ablative tumor radiation doses while preserving kidney function. We report Canada's first use of CyberKnife SABR system in treating primary kidney tumors.
Materials and methods: Between January 2011 and February 2012, we treated three patients with renal tumors using CyberKnife SABR. Two patients had tumors in solitary kidney. The third patient had a recurrent tumor after two previous radiofrequency ablation treatments. Platinum seed fiducials were used for real time tumor tracking. Magnetic… More >

Rachel A. Moses¹, Lawrence M. Dagrosa¹, Elias S. Hyams¹, Peter L. Steinberg², Vernon M. Pais¹

Canadian Journal of Urology, Vol.20, No.5, pp. 6939-6943, 2013

Abstract Introduction: The purpose of this study is to evaluate predictors of poor compliance after treatment of urinary stone disease.
Materials and methods: This study was a retrospective analysis of patients who underwent stent removal following percutaneous nephrolithotomy (PCNL) or ureteroscopy (URS) between 2008-2012. All patients were scheduled for follow up evaluation and renal ultrasound at 4-6 weeks following stent removal. Patients were stratified based on appointment compliance and demographic variables including gender, age, insurance type (Government Assisted Insurance [GAI] or Private Insurance [PI]), initial procedure, season, distance between home and clinic, average monthly gas price at follow… More >

Jay D. Raman

Canadian Journal of Urology, Vol.20, No.5, pp. 6938-6938, 2013

Abstract This article has no abstract. More >

Matthew A. Morgan¹, Nathan R. Roberts², Laura A. Pino¹, Edouard J. Trabulsi^2,3, Daniel B. Brown^1,3, Leonard G. Gomella^2,3, Costas D. Lallas^2,3

Canadian Journal of Urology, Vol.20, No.5, pp. 6933-6937, 2013

Abstract Introduction: Partial nephrectomy has a 3%-4% incidence of local treatment failure. This study is to present a series of percutaneous cryoablation for locally recurrent renal cell carcinoma after partial nephrectomy.
Materials and methods: Five consecutive patients were referred to our quaternary center’s multidisciplinary Small Renal Mass (SRM) Center for assessment after failure of partial nephrectomy. Tumor size and location was noted. CT-guided cryoablation was performed using an argon/helium-based system (Healthtronics, Austin, Texas, USA). Patients were admitted overnight for observation. Patients were followed with serial imaging, laboratory tests and examination at our SRM Center. Tumor size, location, and… More >